Imran Khan “Personally Examines” Non-acceptance of Chinese COVID Vaccine in Middle East, Minister Pak Says
Update: 06 June 2021 19:39 STI
Islamabad [Pakistan], June 6 (NNA): Pakistani Prime Minister Imran Khan “is personally examining” the non-acceptance of the Chinese vaccine against COVID-19 in Saudi Arabia and some other countries in the Middle East, the minister said on Sunday. Interior of the country, Sheikh Rashid.
Addressing a press conference in Islamabad today, the minister said: “[The PM] also told the cabinet that he was in contact with the (Middle Eastern) countries concerned in this regard. “
“Sinopharm is an excellent vaccine and I welcome the Chinese cooperation in this regard,” he said, quoted by The Express Tribune.
Last month, the Sinopharm COVID-19 vaccine developed by a Chinese company received an emergency use list by the World Health Organization (WHO). The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG).
Despite the WHO approval, some concerns about the efficacy and efficacy of the Chinese vaccine still remain unresolved.
Marking a rare admission from China on the effectiveness of its COVID-19 vaccine, the country’s Centers for Disease Control (CDC) said in April that the effectiveness of Chinese coronavirus vaccines was “not high” and that they might need improvement, The Washington Post reported.
Chinese CDC Director George Gao said China is “officially considering” options to modify its vaccines to “solve the problem that the effectiveness of existing vaccines is not high.”
Shortly after Gao’s remarks were made public, the words began to spread quickly on Chinese social media before being mostly censored. Beijing, however, refuted Gao’s comments and said his statement was taken out of context.
Beijing has provided COVID-19 vaccines as public goods by providing medical assistance to 80 countries, exporting vaccines to 43 countries and providing 300 million doses of vaccines globally, China’s national commission informed Thursday. health.
Earlier this week, the WHO validated CoronaVac, the second COVID-19 vaccine developed by a Chinese pharmaceutical company, for emergency use. (ANI)